One model for translational development of a home-grown therapeutic agent from academic laboratories. Timeline for the National Cancer Institute (NCI) development of lymphoma idiotype protein vaccines, with prolonged initial development (phase 1/2, initial phase 3) in academia before transfer of technology for potential commercialization. Abbreviations: IND, investigational new drug.